Speak directly to the analyst to clarify any post sales queries you may have.
As next generation sequencing (NGS) technologies accelerate, senior leaders in pharmaceuticals, diagnostics, and laboratory operations face critical choices in sample preparation workflows. The NGS sample preparation market is evolving rapidly, with efficiency, automation, and regulatory adherence emerging as central decision drivers that influence competitive advantage and organizational resilience.
Market Snapshot: NGS Sample Preparation Market Growth Outlook
The NGS sample preparation market continues on a solid growth trajectory, driven by broadening adoption in both research and clinical settings. Forecasts indicate an increase in market value from USD 2.78 billion in 2024 to USD 3.24 billion in 2025, reaching USD 9.45 billion by 2032. This momentum reflects increased uptake of next generation sequencing and the expansion of actionable genomic applications. As a result, end users are demanding more automated, high-throughput sample preparation processes with robust accuracy and flexibility to address diverse needs. The rising expectations for streamlined workflows underscore the importance of modular solutions and operational agility in supporting long-term market expansion.
Scope & Segmentation: NGS Sample Preparation Market
This executive-focused report delivers comprehensive, actionable analysis across the NGS sample preparation market to empower informed strategic decision-making. Industry segmentation covers the following core categories:
- Product Types: Includes amplification kits encompassing PCR, digital PCR, qPCR, and rolling circle amplification; fragmentation and size selection kits using enzymatic and mechanical methods; RNA and DNA library preparation solutions; and target enrichment products tailored to various genomic applications.
- Applications: Addresses epigenetic research, metagenomics, a spectrum of RNA sequencing formats such as mRNA, small RNA, total RNA, and miRNA, along with oncology, inherited disease screening, and pharmacogenomics workflows.
- Technologies: Details magnetic and solid phase bead-based methods, enzymatic processing, microfluidic solutions including droplet and lab-on-chip platforms, and established PCR-driven approaches.
- Workflow Steps: Maps the full process, from amplification and enrichment to fragmentation, library construction, quantification, and quality assurance.
- End Users: Involves academic and government research centers, contract research organizations, diagnostics laboratories, and pharmaceutical and biotechnology companies with scalable, high-throughput processing needs.
- Regions: Analyzes the Americas (North and Latin America), Europe, Middle East, Africa, and Asia-Pacific, highlighting localized operational drivers and regulatory environments affecting adoption and supplier collaboration.
- Leading Companies: Provides detailed profiles on Illumina, Thermo Fisher Scientific, QIAGEN, Roche Diagnostics, Agilent Technologies, New England Biolabs, Takara Bio, PerkinElmer, Bio-Rad Laboratories, Promega, Merck KGaA, BGI Genomics, Sysmex, and Novogene.
Key Takeaways: Strategic Insights for Senior Decision-Makers
- Consistent and efficient NGS sample preparation is essential to achieve reliable sequencing outcomes and support reproducibility across research and diagnostics initiatives.
- Embracing automation and modular products supports rapid adjustments in laboratory throughput and allows organizations to respond effectively to changing workflow demands and project scales.
- Technologies such as digital PCR and integrated microfluidic platforms broaden potential for advanced genomic analysis, particularly with low-input or single-cell samples.
- Supply chain resilience is a top priority, prompting organizations to adopt adaptive logistics and sourcing models to mitigate risks from raw material and reagent variability.
- Strategic industry alliances and technology partnerships are shaping speed-to-market and facilitating regulatory compliance, particularly in regions with evolving requirements.
- Regional diversity in funding structures, regulatory policies, and healthcare priorities requires tailored procurement strategies and technology choices for optimal performance and compliance.
Tariff Impact on the NGS Sample Preparation Ecosystem
Planned United States tariffs commencing in 2025 introduce new challenges for NGS sample preparation supply chains. Organizations face increased import costs, extended delivery times, and pricing volatility, leading many to reassess procurement strategies, regional manufacturing, and supplier diversification to maintain workflow continuity and competitive positioning.
Methodology & Data Sources
This report utilizes a rigorous methodology, including direct interviews with industry executives, feedback from leading solution providers and key end users, and validation through secondary datasets and patent reviews. Oversight by subject matter experts further ensures the findings are relevant and actionable for leaders.
Why This Report Matters
- Enables executive benchmarking of technology adoption and sample preparation practices, supporting optimized operational and purchasing decisions for NGS workflows.
- Empowers leaders to proactively identify and address supply chain vulnerabilities, regulatory risks, and regional adoption challenges, ensuring operational continuity.
- Presents structured, segment-level analysis of product offerings, technology developments, and competitor positioning to inform both strategic planning and successful market entry or expansion.
Conclusion
Senior decision-makers can gain actionable insights from this report to guide both strategic planning and operational agility within the dynamic NGS sample preparation ecosystem. Leverage this analysis to drive data-supported growth and improve resilience in a complex, rapidly changing market.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this NGS Sample Preparation market report include:- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Roche Diagnostics International Ltd.
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- Takara Bio Inc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- Merck KGaA
- BGI Genomics Co., Ltd.
- Promega Corporation
- Sysmex Corporation
- Novogene Co., Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 183 |
Published | October 2025 |
Forecast Period | 2025 - 2032 |
Estimated Market Value ( USD | $ 3.24 Billion |
Forecasted Market Value ( USD | $ 9.45 Billion |
Compound Annual Growth Rate | 16.5% |
Regions Covered | Global |
No. of Companies Mentioned | 16 |